Advanced search
Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 20
Submit an article Journal homepage
1,638
Views
13
CrossRef citations to date
0
Altmetric
Short Communication

Computational and experimental insights on the interaction of artemisinin, dihydroartemisinin and chloroquine with SARS-CoV-2 spike protein receptor-binding domain (RBD)

Giovanni Ribaudoa Department of Molecular and Translational Medicine, University of Brescia, Brescia, ItalyCorrespondence[email protected] [email protected]
View further author information
,
Paolo Coghib School of Pharmacy, Macau University of Science and Technology, Taipa, Macau, China;c State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau, ChinaCorrespondence[email protected] [email protected]
View further author information
,
Li Jun Yangd Neher’s Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau, ChinaView further author information
,
Jerome P. L. Ngd Neher’s Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau, ChinaView further author information
,
Andrea Mastinua Department of Molecular and Translational Medicine, University of Brescia, Brescia, ItalyView further author information
,
Maurizio Memoa Department of Molecular and Translational Medicine, University of Brescia, Brescia, ItalyView further author information
,
Vincent Kam Wai Wongd Neher’s Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau, ChinaView further author information
&
Alessandra Gianoncellia Department of Molecular and Translational Medicine, University of Brescia, Brescia, ItalyView further author information
 show all
Pages 5358-5363 | Received 17 Mar 2021, Accepted 01 May 2021, Published online: 12 May 2021

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Koji Teshima, Takeshi Tanaka, Zhengmao Ye, Ken Ikeda, Takao Matsuzaki, Tamotsu Shiroma, Ayumu Muroya, Masato Hosoda, Mayo Yasugi & Hirotsugu Komatsu. (2023) Antiviral activity of curcumin and its analogs selected by an artificial intelligence-supported activity prediction system in SARS-CoV-2-infected VeroE6 cells. Natural Product Research 0:0, pages 1-6.
Read now
Paolo Coghi, Xiao Yun Yun, Jerome P. L. Ng, Betty Yuan Kwan Law, Maurizio Memo, Alessandra Gianoncelli, Vincent Kam Wai Wong & Giovanni Ribaudo. (2022) Exploring SARS-CoV-2 Delta variant spike protein receptor-binding domain (RBD) as a target for tanshinones and antimalarials. Natural Product Research 36:23, pages 6150-6155.
Read now

Articles from other publishers (11)

Lin Guan, Huiyong Wang, Xiaolong Xu & Huahao Fan. (2023) Therapeutical Utilization and Repurposing of Artemisinin and Its Derivatives: A Narrative Review. Advanced Biology.
Crossref
Giovanni Ribaudo, Xiaoyun Yun, Alberto Ongaro, Erika Oselladore, Jerome P. L. Ng, Richard K. Haynes, Betty Yuen Kwan Law, Maurizio Memo, Vincent Kam Wai Wong, Paolo Coghi & Alessandra Gianoncelli. (2022) Combining computational and experimental evidence on the activity of antimalarial drugs on papain‐like protease of SARS‐CoV ‐2: A repurposing study . Chemical Biology & Drug Design 101:4, pages 809-818.
Crossref
Md. Rezaul Islam, Md. Mominur Rahman, Puja Sutro Dhar, Feana Tasmim Nowrin, Nasrin Sultana, Muniya Akter, Abdur Rauf, Anees Ahmed Khalil, Alessandra Gianoncelli & Giovanni Ribaudo. (2023) The Role of Natural and Semi-Synthetic Compounds in Ovarian Cancer: Updates on Mechanisms of Action, Current Trends and Perspectives. Molecules 28:5, pages 2070.
Crossref
Hossein Rabbi Angourani, Armin Zarei, Maryam Manafi Moghadam, Ali Ramazani & Andrea Mastinu. (2023) Investigation on the Essential Oils of the Achillea Species: From Chemical Analysis to the In Silico Uptake against SARS-CoV-2 Main Protease. Life 13:2, pages 378.
Crossref
AA Ryabchenkova, VV Kopat, ER Chirak, EL Chirak, IA Leneva, EA Glubokova, NP Kartashova, NN Kolmakov & IV Dukhovlinov. (2022) Assessment of cytotoxicity and antiviral activity against SARS-CoV-2 of the mixture of lactoferrin, artemisinin, and azithromycin in vitro. Medicine of Extreme Situations:2022(4).
Crossref
Thanet Pitakbut, Gia-Nam Nguyen & Oliver Kayser. (2021) Activity of THC, CBD, and CBN on Human ACE2 and SARS-CoV1/2 Main Protease to Understand Antiviral Defense Mechanism. Planta Medica 88:12, pages 1047-1059.
Crossref
Estefanía Calvo-Alvarez, Maria Dolci, Federica Perego, Lucia Signorini, Silvia Parapini, Sarah D’Alessandro, Luca Denti, Nicoletta Basilico, Donatella Taramelli, Pasquale Ferrante & Serena Delbue. (2022) Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey. Microorganisms 10:7, pages 1284.
Crossref
Pawan K. Agrawal, Chandan Agrawal & Gerald Blunden. (2022) Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment?. Molecules 27:12, pages 3828.
Crossref
Océane Delandre, Mathieu Gendrot, Priscilla Jardot, Marion Le Bideau, Manon Boxberger, Céline Boschi, Isabelle Fonta, Joel Mosnier, Sébastien Hutter, Anthony Levasseur, Bernard La Scola & Bruno Pradines. (2022) Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants. Pharmaceuticals 15:4, pages 445.
Crossref
Karim Farmanpour-Kalalagh, Arman Beyraghdar Kashkooli, Alireza Babaei, Ali Rezaei & Alexander R. van der Krol. (2022) Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand. Frontiers in Plant Science 13.
Crossref
Meden F. Isaac-Lam. (2021) Molecular modeling of the interaction of ligands with ACE2–SARS-CoV-2 spike protein complex. In Silico Pharmacology 9:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.